C79.40
Secondary malignant neoplasm of unspecified part of nervous system
Clinical Classification Guidelines
Medical Intelligence & Overview
The diagnosis of secondary malignant neoplasm of the nervous system, coded as ICD-10 C79.40, refers to the presence of cancerous growths that have spread to the nervous system from a primary site elsewhere in the body. These tumors are referred to as secondary because they originate outside the nervous system and metastasize (spread) to it. Such conditions can affect various parts of the nervous system, including the brain, spinal cord, and surrounding tissues. Recognizing and understanding this diagnosis is important for managing the course of the disease and determining appropriate treatment options.
Causes & Symptoms
Clinical Causes: Metastasis from primary cancers located in other parts of the body such as the lung, breast, melanoma, or gastrointestinal tract. Spread through the bloodstream or lymphatic system leading to implantation in nervous tissue. Tumor cells penetrating the blood-brain barrier and establishing secondary growths in nervous tissue.
Key Symptoms: Headaches that worsen over time or are new in onset. Seizures without prior history, especially if new or different in character. Neurological deficits such as weakness, numbness, or paralysis in parts of the body. Changes in vision, hearing, or speech. Cognitive or personality changes, including confusion or memory loss. Nausea and vomiting, often associated with increased intracranial pressure. Balance or coordination problems, including difficulty walking or standing. Sensory disturbances, such as tingling or loss of sensation.
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary malignant neoplasm of the nervous system involves a comprehensive process including medical history, neurological examinations, and imaging studies. Techniques frequently employed include:
Treatment Protocols: Treatment options for secondary malignant neoplasm of the nervous system are usually tailored to the individual and depend on factors such as the primary cancer type, location and size of metastases, patient health, and symptoms. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C79.40 a billable ICD-10 code?
Yes, C79.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.40?
Clinical documentation must specify the nature of Secondary malignant neoplasm of unspecified part of nervous system and any associated comorbidities for accurate reporting.
Cite this Clinical Reference